J Clin Endocrinol Metab 95:134–142CrossRef 22. Burt-Pichat B, Lafage-Proust
MH, Duboeuf F, Laroche N, Itzstein C, Vico L, Delmas PD, Chenu C (2005) Dramatic decrease of innervation density in bone after ovariectomy. Endocrinology 146:503–510PubMedCrossRef 23. Jeyabalan J, Shah M, Viollet B, Roux JP, Chavassieux P, Korbonits M, Chenu C (2012) Mice lacking AMP-activated protein kinase (AMPK)-alpha 1 catalytic subunit have increased bone remodeling and modified skeletal responses to hormonal challenges induced by ovariectomy and intermittent PTH treatment. J Endocrinol 214:349–358PubMedCrossRef 24. Harrison LJ, Cunningham JL, Stromberg L, Goodship AE (2003) Controlled induction of a pseudarthrosis: a study using a rodent model. J Orthop Trauma 17:11–21PubMedCrossRef 25. Amanat N, McDonald M, Godfrey C, Bilston L, Little D (2007) Optimal timing of a single dose of DNA Damage inhibitor zoledronic acid to increase strength in rat fracture
repair. J Bone Miner Res 22:867–876PubMedCrossRef 26. Chappard D, Palle S, Alexandre C, Vico L, Riffat G (1987) Bone embedding in pure methyl methacrylate at low temperature preserves enzyme activities. Acta Histochem 81:183–190PubMedCrossRef 27. Chavassieux learn more PM, Arlot ME, Reda C, Wei L, Yates AJ, Meunier PJ (1997) Histomorphometric assessment of the long-term effects of alendronate from on bone quality and remodeling in patients with osteoporosis. J Clin Invest 100:1475–1480PubMedCrossRef 28. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595–610PubMedCrossRef 29. Zaman G, Sunters A, Galea GL, Javaheri B, Saxon LK, Moustafa A, Armstrong VJ, Price JS, Lanyon LE (2012) Loading-related regulation of transcription factor EGR2/Krox-20 in bone cells is ERK1/2 protein-mediated and prostaglandin, Wnt
signaling pathway-, and insulin-like growth factor-1 axis-dependent. J Biol Chem 287:3946–3962PubMedCrossRef 30. Amini H, Ahmadiani A, Gazerani P (2005) Determination of metformin in human Sirtuin inhibitor plasma by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 824:319–322PubMedCrossRef 31. Kaneb HM, Sharp PS, Rahmani-Kondori N, Wells DJ (2011) Metformin treatment has no beneficial effect in a dose–response survival study in the SOD1(G93A) mouse model of ALS and is harmful in female mice. PLoS One 6:e24189PubMedCrossRef 32. Fryer LG, Parbu-Patel A, Carling D (2002) The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 277:25226–25232PubMedCrossRef 33.